Register Free
Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
MHRA • NHS England • NICE • UKHSA

Clinical News & Alerts

379+ sourced updates — safety alerts, regulatory decisions and NHS England announcements, verified for UK clinicians.

MHRA Safety Alert NHS England NICE Update UKHSA
📰
Clinical News

Latest Alerts & Updates

⚠️ Safety Alert
MHRA Diabetes / Metabolic
GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation
Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who…
28 Jan 2025 View brief →
⚠️ Safety Alert
MHRA
Letters and medicine recalls sent to healthcare professionals in December 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.  This update is best treated as…
28 Jan 2025 View brief →
⚠️ Safety Alert
MHRA
Letters and medicine recalls sent to healthcare professionals in November 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as…
12 Dec 2024 View brief →
⚠️ Safety Alert
MHRA
MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety
The ninth annual #MedSafetyWeek social media campaign is taking place 4 to 10 November 2024. This update is best treated as a…
06 Nov 2024 View brief →
⚠️ Safety Alert
MHRA
Letters and medicine recalls sent to healthcare professionals in October 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as…
06 Nov 2024 View brief →
⚠️ Safety Alert
MHRA Diabetes / Metabolic
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). This…
24 Oct 2024 View brief →
⚠️ Safety Alert
MHRA Diabetes / Metabolic
Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme
We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives. This update…
24 Oct 2024 View brief →
⚠️ Safety Alert
MHRA Cardiology / Cardiovascular
Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation
A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking bromocriptine. The…
24 Oct 2024 View brief →
⚠️ Safety Alert
MHRA
Letters and medicine recalls sent to healthcare professionals in September 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as…
24 Oct 2024 View brief →
⚠️ Safety Alert
MHRA
Letters and medicine recalls sent to healthcare professionals in August 2024
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. This update is best treated as…
26 Sep 2024 View brief →